BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3089098)

  • 1. Relation between risk of breast cancer and biological availability of estradiol in the blood: prospective study in Guernsey.
    Bulbrook RD; Moore JW; Clark GM; Wang DY; Millis RR; Hayward JL
    Ann N Y Acad Sci; 1986; 464():378-88. PubMed ID: 3089098
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of oestradiol to blood proteins and aetiology of breast cancer.
    Moore JW; Clark GM; Hoare SA; Millis RR; Hayward JL; Quinlan MK; Wang DY; Bulbrook RD
    Int J Cancer; 1986 Nov; 38(5):625-30. PubMed ID: 3770991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of estradiol as a marker for breast cancer risk assessment.
    Jones LA; Ota DM; Jackson GA; Jackson PM; Kemp K; Anderson DE; McCamant SK; Bauman DH
    Cancer Res; 1987 Oct; 47(19):5224-9. PubMed ID: 3621208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sex hormone-binding globulin capacity and the percentage of free estradiol in postmenopausal women with and without endometrial carcinoma. A new biochemical basis for the association between obesity and endometrial carcinoma.
    Nisker JA; Hammond GL; Davidson BJ; Frumar AM; Takaki NK; Judd HL; Siiteri PK
    Am J Obstet Gynecol; 1980 Nov; 138(6):637-42. PubMed ID: 7192053
    [No Abstract]   [Full Text] [Related]  

  • 5. A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey.
    Thomas HV; Key TJ; Allen DS; Moore JW; Dowsett M; Fentiman IS; Wang DY
    Br J Cancer; 1997; 75(7):1075-9. PubMed ID: 9083346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, non-protein-bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients.
    Ota DM; Jones LA; Jackson GL; Jackson PM; Kemp K; Bauman D
    Cancer; 1986 Feb; 57(3):558-62. PubMed ID: 3942990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo availability of circulating estradiol in postmenopausal women with and without endometrial cancer.
    Gambone JC; Pardridge WM; Lagasse LD; Judd HL
    Obstet Gynecol; 1982 Apr; 59(4):416-21. PubMed ID: 7200594
    [No Abstract]   [Full Text] [Related]  

  • 8. Relations of insulin resistance and serum concentrations of estradiol and sex hormone-binding globulin to potential breast cancer risk factors.
    Nagata C; Shimizu H; Takami R; Hayashi M; Takeda N; Yasuda K
    Jpn J Cancer Res; 2000 Sep; 91(9):948-53. PubMed ID: 11011124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen binding and risk factors for breast cancer.
    Ingram DM; Nottage EM; Willcox DL; Roberts A
    Br J Cancer; 1990 Feb; 61(2):303-7. PubMed ID: 2310682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens and breast cancer.
    Siiteri PK; Simberg N; Murai J
    Ann N Y Acad Sci; 1986; 464():100-5. PubMed ID: 3460371
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sex hormone-binding globulin in breast cancer].
    Suminaga Y; Morimoto T; Komaki K; Mori T; Monden Y
    Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):875-82. PubMed ID: 2398880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women.
    Zeleniuch-Jacquotte A; Bruning PF; Bonfrer JM; Koenig KL; Shore RE; Kim MY; Pasternack BS; Toniolo P
    Am J Epidemiol; 1997 Jun; 145(11):1030-8. PubMed ID: 9169912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of endogenous estrogens and breast cancer in postmenopausal women.
    Toniolo PG; Levitz M; Zeleniuch-Jacquotte A; Banerjee S; Koenig KL; Shore RE; Strax P; Pasternack BS
    J Natl Cancer Inst; 1995 Feb; 87(3):190-7. PubMed ID: 7707406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of estradiol and breast cancer in Japanese women.
    Kabuto M; Akiba S; Stevens RG; Neriishi K; Land CE
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):575-9. PubMed ID: 10868691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous sex hormones, prolactin, and breast cancer in premenopausal women.
    Meyer F; Brown JB; Morrison AS; MacMahon B
    J Natl Cancer Inst; 1986 Sep; 77(3):613-6. PubMed ID: 3462404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol binding to plasma proteins after changing to a low-fat diet.
    Ingram D; Bennett F; Wood A
    Nutr Cancer; 1989; 12(4):327-32. PubMed ID: 2608537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between hormone dependence and metastasis in breast cancer--SHBG assay in the study of breast cancer metastases].
    Murayama Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):7-9. PubMed ID: 3611893
    [No Abstract]   [Full Text] [Related]  

  • 18. Free estradiol in postmenopausal women with and without endometrial cancer.
    Davidson BJ; Gambone JC; Lagasse LD; Castaldo TW; Hammond GL; Siiteri PK; Judd HL
    J Clin Endocrinol Metab; 1981 Mar; 52(3):404-8. PubMed ID: 7193218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk.
    Bruning PF; Bonfrèr JM; Hart AA
    Br J Cancer; 1985 Apr; 51(4):479-84. PubMed ID: 4038881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients.
    Rose DP; Chlebowski RT; Connolly JM; Jones LA; Wynder EL
    Cancer Res; 1992 Oct; 52(19):5386-90. PubMed ID: 1394142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.